FDA approves first treatment of progeria
Treatment for the disease — characterized by dramatic, rapid aging beginning in childhood — was made possible after nearly two decades of NIH research.
FOR HEALTH PROFESSIONALS
About the National Human Genome Research Institute
At NHGRI, we are focused on advances in genomics research. Building on our leadership role in the initial sequencing of the human genome, we collaborate with the world's scientific and medical communities to enhance genomic technologies that accelerate breakthroughs and improve lives. By empowering and expanding the field of genomics, we can benefit all of humankind.